In an age where medical treatments often come with a long list of side effects, BPC 157 stands out
He also said the FDA reviews "establish that for all of the seven peptides the evidence for efficacy is either extremely thin or non-existent." Lurie said that there are several risks consumers face when buying peptides currently, including "contaminants, especially infection, due to poor compounding practices, wasteful expenditures of funds of products that are not known to work, and, perhaps most importantly, diversion from actually effective products approved by FDA." He added that he thought there "should be research on these and patients can enroll in trials
Liquid formula may be mixed into a small amount of juice for palatability
Expert Opin Invest Drugs 2002
The Core Focus: Smaller, modular portion sizes Enhanced focus on protein-forward items Shifting "value" messaging away from pure volume Can a fast-food brand successfully market "portion control," or will GLP-1 users simply abandon the drive-thru altogether
10.1016/j.bcp.2021.114563 Biochem